– CANADA, Burlington – Rapid Dose Therapeutics Corp. (CSE: DOSE) today announced the appointment of John McKimm to its Board as an independent director, replacing Jason Lewis who resigned from the Board but will continue in his role as SVP of Business Development.
John McKimm has also joined the audit committee.
About John McKimm
John McKimm is currently CEO of Smart Employee Benefits Inc., an insurtech company focused on benefits administration technology driving two interrelated revenue streams – benefits solutions and technology services. Mr. McKimm’s experience spans over 35 years of serving as a director and an officer of many public and private companies, where he provided operations, investment banking, and corporate finance expertise. This experience covers a range of sectors, including, healthcare, food processing, biotechnology, and retail. He has personally identified, negotiated, and executed more than 150 individual mergers, acquisitions, and financing transactions, both as a principal and as an agent. Mr. McKimm possesses deep knowledge in dealing with emerging and growth companies, specifically concerning providing specialty services in government funding programs, strategic and financial restructurings, mergers and acquisitions, operational and financial restructuring, and the arrangement of financings. Mr. McKimm’s experience is global.
Mr. McKimm is a graduate of the University of New Brunswick with a Bachelor of Business Administration and a graduate of the University of Western Ontario with an MBA and a Bachelor of Laws. Mr. McKimm also has several investment industry certifications and designations. He has published on select investment and financial restructuring topics.
About Rapid Dose Therapeutics Corp.
Rapid Dose Therapeutics is a Canadian biotechnology company revolutionizing drug delivery through innovation. The Company’s flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals, and vaccines, that are delivered quickly into the bloodstream, resulting in rapid onset of the active ingredient.
For more information: https://www.rapid-dose.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.